1.5 - 3 g IV Q8H
No dose adjustment
Data is insufficient in the Pediatric population
Infectious Diseases consult required for use.
Should be reserved for patients with little or no other treatment alternatives.
Reserved primarily for management of documented infections caused by CRE
In patients with documented multi-drug resistant (MDR) pseudomonas or CRE organisms
Antimicrobial class: Cephalosporin Combination
Pregnancy category: B